| For: | Hao XW, Zhu ST, He YL, Li P, Wang YJ, Zhang ST. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18(6): 532-540 [PMID: 22363119 DOI: 10.3748/wjg.v18.i6.532] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i6/532.htm |
| Number | Citing Articles |
| 1 |
Li Shang, Mingrong Wang. Molecular alterations and clinical relevance in esophageal squamous cell carcinoma. Frontiers of Medicine 2013; 7(4) doi: 10.1007/s11684-013-0286-y
|
| 2 |
Raghibul Hasan, Gunjan Srivastava, Akram Alyass, Rinu Sharma, Anoop Saraya, Tushar K. Chattopadhyay, Siddartha DattaGupta, Paul G. Walfish, Shyam S. Chauhan, Ranju Ralhan. Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model. Oncotarget 2022; 13(1) doi: 10.18632/oncotarget.10656
|
| 3 |
Zhou Chen, Xiaopei Guo, Maikel P. Peppelenbosch, Gwenny M. Fuhler. WNT/β-catenin signaling: implications for homeostasis and tumorigenesis in the esophagus. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2026; 1881(6) doi: 10.1016/j.bbcan.2026.189722
|
| 4 |
Pere Llinàs-Arias, Manel Esteller. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update. Open Biology 2017; 7(9) doi: 10.1098/rsob.170152
|
| 5 |
The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819877977
|
| 6 |
Hongxiao Wang, Zijun Song, Enjun Xie, Junyi Chen, Biyao Tang, Fudi Wang, Junxia Min. Targeting the LSD1-G9a-ER Stress Pathway as a Novel Therapeutic Strategy for Esophageal Squamous Cell Carcinoma. Research 2022; 2022 doi: 10.34133/2022/9814652
|
| 7 |
Xiao‐Song Ge, Hua‐Juan Ma, Xiao‐Hui Zheng, Hong‐Lian Ruan, Xiao‐Yu Liao, Wen‐Qiong Xue, Yuan‐Bin Chen, Ying Zhang, Wei‐Hua Jia. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF‐1 expression and activates Wnt pathway. Cancer Science 2013; 104(12) doi: 10.1111/cas.12296
|
| 8 |
Yasushi Toh, Akinori Egashira, Manabu Yamamoto, Shohei Yamaguchi. Interplay among epigenetic alterations and crosstalk between genetic and epigenetic alterations in esophageal squamous cell carcinoma. Esophagus 2014; 11(3) doi: 10.1007/s10388-014-0431-y
|
| 9 |
Jun Yu, Yang Xie, Mengying Li, Fenfang Zhou, Zhenyang Zhong, Yuting Liu, Feng Wang, Jian Qi. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis. Oncology Letters 2019; doi: 10.3892/ol.2019.10709
|
| 10 |
Vanessa Ortiz-Barahona, Ricky S. Joshi, Manel Esteller. Use of DNA methylation profiling in translational oncology. Seminars in Cancer Biology 2022; 83 doi: 10.1016/j.semcancer.2020.12.011
|
| 11 |
Long Liao, Zi‐Ting Yao, Wang‐Kai Fang, Qing‐Yu He, Wen Wen Xu, Bin Li. Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics. Small Methods 2020; 4(10) doi: 10.1002/smtd.202000391
|
| 12 |
Fatemeh Ardalan Moghadam Al, Mohammad Mahdi Forghanifard, Vajiheh Zarrinpour. PYGO2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinoma. Journal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23625
|
| 13 |
Yu Lian, Xiangdong Niu, Hui Cai, Xiaojun Yang, Haizhong Ma, Shixun Ma, Yupeng Zhang, Yifeng Chen. Clinicopathological significance of c-MYC in esophageal squamous cell carcinoma. Tumor Biology 2017; 39(7) doi: 10.1177/1010428317715804
|